Notably, the phosphatidylinositol 3-kinase-protein kinase B (PI3K/AKT) pathway is frequently activated in pancreatic cancer (8), but its upstream regulatory mechanisms—particularly how ECM components trigger this pathway through membrane receptors such as integrins—have not been systematically analyzed. The gene discussed is PIK3CA; the disease is pancreatic neoplasm.